Congratulations to MCB funded-researcher Dr. Frances Arnold, recipient of the 2018 Noble Prize in chemistry. Dr. Arnold is honored for her role in developing the field of directed evolution. As a researcher at California Institute of Technology, Dr. Arnold based her work on the principles of evolution to improve enzyme function; she used error prone polymerase chain reaction (PCR) to introduce random mutations in a gene of interest, introduced those genes into an E. coli library, allowed the mutants to compete, and selected for mutants that improved function. Enzymes optimized through this process can improve results anywhere enzymes are used such as: medicine, biotechnology, biofuels, research, industrial production, and home cleaning and processing applications.
“Dr. Arnold transformed the field of protein engineering and did so at a time when there were very few women in the field. She combatted gender bias in academia by excelling and demonstrating to those of us who followed her that it was possible,” observed Theresa Good, Deputy Division Director of MCB. Dr. Arnold’s award brings the total number of female awardees in chemistry to five of 180 recipients, representing 2.8 percent of awards in chemistry; the percent of all Nobel Prizes awarded to women is slightly less than six percent.
This year’s award is shared with Dr. George P. Smith, University of Missouri, and Dr. Gregory Winter, Medical Research Council Laboratory of Molecular Biology, Cambridge, UK, for their work on phage display. Click on the link to read the Statement on the Nobel Prize in Chemistry by NSF Director Dr. Frances Córdova.